Multiple sclerosis relapse and Heavy or prolong menstrual bleeding

Summary:

Heavy or prolong menstrual bleeding is found among people with Multiple sclerosis relapse, especially for people who are female, 30-39 old.

The study analyzes which people have Heavy or prolong menstrual bleeding with Multiple sclerosis relapse. It is created by eHealthMe based on reports of 22 people who have Multiple sclerosis relapse from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis relapse?

Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,033 drugs and 943 conditions by eHealthMe. Check the latest studies of Multiple sclerosis relapse.

What is Heavy or prolong menstrual bleeding?

Heavy or prolong menstrual bleeding is found to be associated with 750 drugs and 1,264 conditions by eHealthMe. Check the latest studies of Heavy or prolong menstrual bleeding.

On Jul, 11, 2026

22 people who have Multiple Sclerosis Relapse and Heavy Or Prolong Menstrual Bleeding are studied.

Would you have Heavy or prolong menstrual bleeding when you have Multiple sclerosis relapse?

Gender of people who have Multiple Sclerosis Relapse and experienced Heavy Or Prolong Menstrual Bleeding *:

female: 100 %
male: 0.0 %

Age of people who have Multiple Sclerosis Relapse and experienced Heavy Or Prolong Menstrual Bleeding *:

Common co-existing conditions for these people *:

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 14 people, 63.64%
Asthma: 7 people, 31.82%
Gait Disturbance: 4 people, 18.18%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 4 people, 18.18%
Birth Control: 2 people, 9.09%
High Blood Pressure: 1 person, 4.55%
Breast Infection: 1 person, 4.55%

Common drugs taken by these people *:

Common symptoms for these people *:

Headache (pain in head): 17 people, 77.27%
Dizziness: 15 people, 68.18%
Burning Sensation: 11 people, 50.00%
Dysmenorrhea (painful menstruation): 11 people, 50.00%
Skin Blushing/flushing (a sudden reddening of the face, neck): 11 people, 50.00%
Constipation: 11 people, 50.00%
Hypoaesthesia (reduced sense of touch or sensation): 11 people, 50.00%
Weakness: 11 people, 50.00%
Vision Blurred: 11 people, 50.00%
Nausea And Vomiting: 9 people, 40.91%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Heavy or prolong menstrual bleeding?

- Check whether Heavy or prolong menstrual bleeding is associated with a drug or a condition

Related publications that referenced our studies

Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .

Related studies:

Treatments, associated drugs and conditions:

Multiple sclerosis relapse (89,124 reports)
Heavy or prolong menstrual bleeding (38,063 reports)

All the drugs that are associated with Heavy or prolong menstrual bleeding:

Heavy or prolong menstrual bleeding (750 drugs)

All the conditions that are associated with Heavy or prolong menstrual bleeding:

Heavy or prolong menstrual bleeding (1,264 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Heavy or prolong menstrual bleeding and Multiple sclerosis relapse, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.